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Summary 
Neomycin and related aminoglycosidic antibiotics displace calcium from 
synaptosomes of guinea pig cerebral cortex and from preparations of phospha- 
tidylinositol diphosphate. At low drug concentrations, inhibition of  synapto- 
somal calcium binding is competit ive (Ki = 3" 10 -s M), at high concentrations 
it is non-competit ive (K i = 4 . 1 0  -4 M). Monomolecular  films of phosphatidyl- 
inositol diphosphate are contracted by low concentrations of neomycin in the 
subphase, and are expanded at high concentrations. This expansion persists 
even at the collapse pressure indicating a strong interaction between the drug 
and the lipid. 
Neomycin,  s t reptomycin and related aminoglycosidic antibiotics exert  
two types of toxic actions on mammalian tissues. Neuromuscular and 
ganglionic toxicity are acute effects antagonized by Ca 2 +, while chronic ap- 
plication of  these drugs leads to irreversible cochlear and to renal damage [1]. 
Concentrat ion-dependent  dual effects of aminoglycosides on some tissues have 
been reported. In the small intestine of the rat, 6 mM neomycin reversibly in- 
creases glucose absorption while 18 mM drug irreversibly inhibits it [2]. 
St reptomycin suppresses the microphonic output  of  the fish lateral line organ 
reversibly at concentrations around 2" 10 -s M and irreversibly at concentrat ion 
tions above 10 -2 M [3]. 
We have recently demonstrated an inhibition by neomycin of poly- 
phosphoinosit ide metabolism in vivo in the inner ear [4] of chronically treated 
guinea pigs. In vitro, this antibiotic was shown to interfere with polyphospho- 
inositide metabolism and calcium binding in inner ear tissues [4] and with 
lipid labeling in synaptosomes from cerebral cortex [5]. We, therefore, in- 
vestigated possible correlations between the neomycin action on calcium bind- 
ing and on polyphosphoinosi t ides with synaptosomal membranes and with 
monomolecular  films of phosphatidylinositol  diphosphate.  
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Neomycin which inhibits calcium binding at the vascular smooth muscle 
[6] is also a po ten t  inhibitor of calcium binding to synaptosomal membranes 
(Table I). The structurally related antibiotics tobramycin,  gentamicin and 
kanamycin show similar activity. Of the various drug fragments tested, the 
most  effective were neamine and neobiosamine, which are moieties of neo- 
mycin. At low concentrations neomycin inhibits calcium binding competitive- 
ly but  at higher concentrations the inhibition is non-competit ive (Fig. 1). This 
was confirmed in several independent  experiments with different synaptosomal 
preparations. From these experiments constants were calculated [ 7] for cal- 
cium binding (Km = 6" 10 -4 M), for the competitive inhibition by neomycin 
(K i = 3" 10 -s M) and the non-competit ive inhibition (K i = 4" 10 -4 M). 
Both proteins and lipids are calcium binding sites in biological mem- 
branes but  drug-calcium interactions generally involve calcium bound to 
phospholipids [8]. In view of the neomycin action on polyphosphoinosi t ide 
metabolism and the known capability of phosphatidylinositol  diphosphate to 
form calcium salts in vitro [9],  we investigated neomycin interactions with this 
lipid. Calcium bound to a phosphatidylinositol  diphosphate preparation is 
readily displaced by neomycin (Table II). In phosphatidylinositol diphosphate 
rich monolayers,  the addition of 10 -2 M Ca 2+ to the subphase results in a con- 
densation of the film (Fig. 2). Neomycin,  at 10 -3 M, produces a strong conden- 
sation at low film pressures. As the surface pressure is increased, the condensa- 
tion effect  diminishes and the curve becomes almost superimposable with the 
standard curve at about  30 dynes/cm. The presence of  10 -2 M neomycin in 
the subphase causes a significant expansion of the film which is evident even at 
the collapse pressure. This indicates a strong interaction between the lipid and 
neomycin at this drug concentration. 
T A B L E  I 
I N H I B I T I O N  O F  C A L C I U M  B I N D I N G  BY A M I N O G L Y C O S I D I C  A N T I B I O T I C S  A N D  F R A G M E N T S  
Lyse d  s y n a p t o s o m e s  (0 .5  m g  prote in )  prepared f r o m  guinea  pig  cerebral  c o r t e x  as descr ibed  prev ious ly  
[ 1 0 ] ,  w e r e  i ncubat ed  for  15  r a i n  a t  3 7 ° C  in 1 0 0  m M  s o d i u m - H E P E S ,  p H  7.4 ,  a n d  0 .1 /~Ci  (0 .1  r aM)  
4SCaC12, v o l u m e  0 .5  ml.  B o u n d  c a l c i u m  was  a s s a y e d  b y  c e n t r i f u g a l  s e d i m e n t a t i o n  [ 4 ] .  N u m b e r s  are 
m e a n s  o f  at l eas t  dupl icate  d e t e r m in at ion s .  In  all e x p e r i m e n t s :  n e o m y c i n  = n e o m y c i n  B. 
C a l c i u m  b o u n d  (% o f  c o n t r o l )  
10 -4 M drug 10 -3 M 
N e o m y c i n  52  4 2  
T o b r a m y c i n  56 4 8  
G e n t a m i c i n  6 1  4 7  
K a n a m y c i n  72  4 2  
S t r e p t o m y c i n  77 5 5  
D i h y d r o s t r e p t o m y c i n  81 61  
B l u e n s o m y c i n  1 1 0  9 8  
N e a m i n e  69  54 
N e o b i o s a m i n e  8 4  56 
N e o s a m i n e  8 2  6 3  
D i h y d r  os trept  o b i o s a m i n e  89  6 0  
Strep  t o b i o s a m i n e  9 2  6 7  
M e t h y l - n e o b i o s a m i n e  81 82  
2 - D e o x y s t r e p t a m i n e  89  76 
Strept id ine  9 0  77  
S t r ep  t a m i n e  9 9  91  
3-De ox y - 3 - a m i n o g l u c  ose 1 0 7  1 0 0  
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Fig.  I .  I n h i b i t i o n  b y  n e o m y c i n  o f  c a l c i u m  b i n d i n g  t o  s y n a p t o s o m a l  m e m b r a n e s .  L y s e d  s y n a p t o s o m e s  [ 1 0 ]  
(0 .6  m g  p r o t e i n )  w e r e  i n c u b a t e d  f o r  3 0  m i n  a t  3 7 ° C  in 7 0  m M  s o d i u m - H E P E S ,  p H  7 .4 ,  w i t h  C a C l l  
( 0 .2  ~Ci  45CaC!~) a n d  n e o m y c i n  as i n d i c a t e d ;  v o l u m e  0 . 5  ml .  N e o m y c i n  w a s  a d d e d  10  r a i n  p r i o r  to  t h e  
a d d i t i o n  o f  C a  2 . B o u n d  c a l c i u m  w a s  a s s a y e d  o n  f i l t e r  d i scs  (Met r i ce l  GN-6) .  E a c h  p o i n t  is t he  m e a n  of  
d u p l i c a t e  d e t e r m i n a t i o n s ;  f i l t e r  b l a n k s  ( i n c u b a t i o n s  w i t h o u t  p r o t e i n )  w e r e  s u b t r a c t e d ,  o - - o ,  n o  neD- 
m y c i n ;  ~----~, 3 • 1 0  -5  M; D - - o  1 0  -4 M; o-- - -# ,  3 • 1 0  -4 M; ~----~,  1 0  -3 M n e o m y c i n .  
T A B L E  II 
I N H I B I T I O N  B Y  N E O M Y C I N  O F  C A L C I U M  B I N D I N G  T O  P H O S P H A T I D Y L I N O S I T O L  
D I P H O S P H A T E  
A p p r o x i m a t e l y  0 .1  ~ m o l  p h o s p h a t i d y l i n o s i t o l  d i p h o s p h a t e  ( p r e p a r e d  a f t e r  H e n d r i c k s o n  a n d  Ba l lou  [ 11 ] ,  
p u r i t y  b y  t h i n  l a y e r  c h r o m a t o g r a p h y  [ 4 ] :  ~ 70% p h o s p h a t i d y l i n o s i t o l  d i p h o s p h a t e ,  1 5 - - 2 0 ~  p h o s p h a t i -  
d y l i n o s i t o l  p h o s p h a t e )  w a s  d i s so lved  in  0 .2  m l  c h l o r o f o r m / m e t h a n o l  (2  : 1) a n d  v i g o r o u s l y  m i x e d  f o r  
1 m i n  w i t h  0 .2  m l  s o d i u m - H E P E S ,  p H  7.4 ,  c o n t a i n i n g  4SCaCl~ a n d  n e o m y c i n .  A f t e r  c e n t r i f u g a t i o n ,  
c a l c i u m  in  the  c h l o r o f o r m  p h a s e  w a s  m e a s u r e d .  N u m b e r s  are  m e a n s  o f  f o u r  d e t e r m i n a t i o n s  w i t h  S.D.  
less t h a n  5%. 
C a l c i u m  b o u n d  ( n m o l )  
0 . 5  m M  CaC12 1 . 0  m M  
0 n e o m y c i n  6 6  78  
0 .2  m M  n e o m y c i n  4 8  56  
0 .5  m M  n e o m y c i n  33  3 8  
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Fig.  2. E f f e c t s  o f  c a l c i u m  a n d  n e o m y c i n  o n  p h o s p h a t i d y l i n o s i t o l  d i p h o s p h a t e  r i ch  m o n o m o l e c u l a r  fi lms. 
The  f i lm b a l a n c e  a s s e m b l y  h a s  b e e n  d e s c r i b e d  p r e v i o u s l y  [ 1 2 ] .  The  s u b p h a s e  c o n s i s t e d  o f  0 .1  M Tris  
ch lo r ide ,  p H  7 .4 ,  a n d  NaC1 to  give a n  ion ic  s t r e n g t h  o f  0 .2 .  A p p r o x i m a t e l y  4 0  # g  p h o s p h a t i d y l i n o s i t o l  
d i p h o s p h a t e  (see l e g e n d  to  T a b l e  II) in  h e x a n o l / e t h a n o l  (9 : 1, b y  vol . )  w e r e  s p r e a d  over  t he  s u b p h a s e  
w i t h  a n  A g l a  m i c r o m e t e r  sy r inge .  S u r f a c e  a r e a  o f  the  t r o u g h  was  1 5  c m  x 3 0  c m  ( 1 0 0 %  a r e a  o n  x-axis) .  
4 5  r a i n  were  a l l o w e d  fo r  e q u i l i b r a t i o n  p r i o r  t o  c o m p r e s s i o n  o f  t he  f i lm,  a n d  one  m i n u t e  w a s  a l l o w e d  
b e t w e e n  e a c h  a r e a  change .  CaC12 or  n e o m y c i n  w e r e  a d d e d  t o  the  s u b p h a s e  in  t he  c o n c e n t r a t i o n s  indi-  
c a t e d .  E a c h  p o i n t  is t h e  m e a n  of  d u p l i c a t e  d e t e r m i n a t i o n s .  
In summary, we have demonstrated an interaction of neomycin with 
calcium binding in synaptosomal membranes and with monomolecular films 
of phosphatidylinositol phosphate. It is intriguing that in both systems the 
drug exerts a dual effect, as its pharmacological actions also seem to show two 
distinct mechanisms. It remains to be established, however, how the in vitro 
effects on calcium binding and on polyphosphoinositides relate to each other 
and to the in vivo toxicity of neomycin. 
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